Stress Echocardiography

Stress echocardiography (SE) rests on a single unifying principle: myocardium downstream of a significant coronary stenosis has adequate blood flow at rest, so resting wall motion looks normal — but when cardiac workload rises and oxygen demand outstrips the limited supply the stenotic vessel can deliver, that segment fails to augment its contraction, or actively worsens. Making that failure visible is the entire point of the test. This page covers the physiology behind each stressor, dosing protocols, the diagnostic framework used to interpret wall motion, safety, and the major clinical applications beyond simple ischemia detection.

Mechanisms of Ischemia

Exercise, dobutamine, and pacing provoke ischemia primarily by increasing cardiac work and oxygen demand beyond what a stenotic artery can supply. Vasodilator stressors (dipyridamole, adenosine) work differently: maximal vasodilation produces flow heterogeneity because the hyperemic response is limited in the territory downstream of a stenosis, with subendocardial perfusion further reduced by adenosine accumulation. This has also been attributed to coronary steal — sometimes called the “reverse Robin Hood effect” — where vasodilated, normally-perfused territory draws flow away from the stenotic territory. Two forms are described: horizontal steal, where vasodilation of a nonstenosed artery’s distal bed lowers collateral perfusion pressure to the stenosed territory, and vertical steal, where vasodilator-induced depressurization of the stenotic territory’s microcirculation collapses subendocardial vessels under higher extravascular pressure, redirecting flow toward the subepicardium.

Increased inotropic state combined with the loading changes seen with stress — particularly with dobutamine, which reduces end-diastolic and end-systolic volumes — can produce LV cavity obliteration. This is a genuine source of false-negative results: transmural wall stress falls, and the area over which a wall motion abnormality could even be identified shrinks.

Physiology of Each Stressor

• Treadmill/bicycle exercise — increases heart rate (sympathetic activation, parasympathetic withdrawal), inotropic state, and systolic blood pressure, while systemic vascular resistance falls and venous return rises. Treadmill exercise achieves higher oxygen consumption than bicycle exercise. Isometric (handgrip) exercise produces the opposite loading pattern — SVR rises and venous return falls.
• Dobutamine — acts primarily via β1 receptors. At low doses, contractility improves without significant tachycardia; above 20 mcg/kg/min, systolic blood pressure rises roughly 30–40 mmHg (to ~170 mmHg) and heart rate roughly 40–50 bpm (to ~120 bpm). A blood pressure fall at higher doses is common, usually from β2-mediated vasodilation.
• Dipyridamole, adenosine, and regadenoson — all act through the same adenosine pathway (dipyridamole raises endogenous adenosine; adenosine and regadenoson act directly). All three produce a small BP decrease and modest tachycardia, with only a minor increase in myocardial function.
• Pacing — increases cardiac work through tachycardia (typically to 160 bpm) alone, with stable loading and blood pressure — better hemodynamic control than other stressors, but the resulting rate-pressure product increment is only modest since blood pressure doesn’t rise meaningfully. Atrial pacing is preferred over ventricular, since asynchronous ventricular contraction from RV pacing complicates wall motion interpretation.
• Ergonovine — considered the gold standard for diagnosing coronary vasospasm, via β-adrenergic, dopaminergic, and serotonin receptor agonism.

Choosing a Stressor

Exercise and pharmacologic stress serve genuinely different purposes, and the choice isn’t arbitrary:

Factor	Exercise	Pharmacologic
IV line required	No	Yes
Diagnostic value of the HR/BP response itself	Yes	Limited
Usable in deconditioned or physically limited patients	No	Yes
Imaging difficulty	Higher (especially treadmill)	Lower
Safety profile	Higher	Moderate
Useful in valvular heart disease	Yes	Limited
Useful in pulmonary hypertension evaluation	Yes	Limited
Assesses fatigue/dyspnea directly	Yes	No

Pharmacologic stress is the default choice when exercise is unfeasible or contraindicated (severe hypertension, inability to exercise adequately, intermittent claudication) or when the resting ECG (e.g., LBBB) would make ischemic ECG changes uninterpretable regardless of stressor. Between dobutamine and a vasodilator, the choice comes down to specific contraindications, patient characteristics, drug cost, and operator preference — dobutamine should generally be avoided in patients with a history of complex atrial or ventricular arrhythmias or with moderate-to- severe hypertension, who should be directed to vasodilator stress instead.

Stress Protocols

Stressor	Equipment	Protocol
Exercise (bicycle)	Semi-supine ergometer	25 W × 2 min stages, incremental loading
Dobutamine	Infusion pump	5 mcg/kg/min, increasing every 3 min to 10–20–30–40; atropine (0.25 mg × up to 4) if no endpoint reached
Dipyridamole	Syringe	0.84 mg/kg over 10 min (0.56 mg/kg/4 min + pause + 0.28 mg/kg/2 min), or the same dose over 6 min (“accelerated protocol,” no atropine needed); atropine if no endpoint
Adenosine	Syringe	140 mcg/kg/min over 6 min
Pacing	External pacer	From 100 bpm, +10 bpm every 2 min to target heart rate

A few protocol-specific points worth knowing:

• Dobutamine: more conservative protocols (peak 20–30 mcg/kg/min) show unsatisfactory sensitivity; more aggressive protocols (peak 50–60 mcg/kg/min, atropine up to 2 mg) haven’t shown proven benefit and raise safety concerns. Myocardial viability specifically is assessed at low doses (5–10 mcg/kg/min) — a materially different endpoint from the ischemia protocol’s full dose escalation.
• Dipyridamole: shorter infusion time gives higher sensitivity, which is why the 6-minute accelerated protocol is often preferred. Aminophylline (240 mg IV) should be available for any adverse event and is routinely given at the end of the test regardless of outcome. Patients should avoid caffeine for 24 hours beforehand, and patients on chronic xanthine medication shouldn’t undergo dipyridamole stress at all.
• Adenosine: its very short half-life means wall motion and coronary flow velocity reserve can’t practically be assessed together in the same test, unlike dipyridamole.
• Treadmill vs. bicycle: treadmill imaging is necessarily post-exercise only (images must be captured within under 1 minute of stopping, before a transiently ischemic segment recovers and produces a false negative), while bicycle (semi-supine) allows imaging during exercise at each workload stage — a real practical advantage, offset by the lower workload most patients can sustain on a bicycle and somewhat less validated exercise-duration and prognostic data.

Image Acquisition and Interpretation

Standard views are the parasternal long- and short-axis, and the apical four-, two-, and long-axis views (subcostal occasionally substituted). Images are recorded at rest, then at each subsequent stage, in a side-by-side digital cine-loop quad-screen format — this is essential, since the heart rate change between rest and stress makes wall motion comparison unreliable without a fixed frame reference. The same views must be obtained at every stage, including recovery (after cessation of exercise/pacing, or after the antidote — aminophylline for dipyridamole, a beta-blocker for dobutamine, nitroglycerin for ergonovine) since an ischemic response can occasionally appear late. This allows a triple comparison: stress vs. rest, stress vs. recovery, and at peak stress itself.

Regional wall motion is graded on a 16- or 17-segment model, using a semiquantitative 4-point scale: 1 = normal, 2 = hypokinetic, 3 = akinetic, 4 = dyskinetic (Otto’s scheme adds a fifth category, aneurysmal — a diastolic contour abnormality with dyskinesis). The wall motion score index (WMSI) is the sum of individual segment scores divided by the number of interpretable segments. Maximum workload for exercise is commonly approximated as heart rate × systolic blood pressure (the rate-pressure product).

The Four Equations

Four diagnostic patterns describe essentially all stress echo responses:

Rest	+ Stress	= Diagnosis
Normokinesis	Normo-/hyperkinesis	Normal
Normokinesis	Hypo-, a-, or dyskinesis	Ischemia
Akinesis	Improves (hypo- or normokinesis)	Viable
A- or dyskinesis	Unchanged	Necrosis (scar)

A biphasic response — improvement at low-dose stress followed by deterioration at peak — indicates both viability and ischemia together: jeopardized myocardium fed by a critically stenotic vessel. One subtlety worth knowing: resting akinesis that becomes dyskinesis under stress is a passive phenomenon from increased intraventricular pressure acting on a normally-contracting wall elsewhere, and shouldn’t be mistaken for true active ischemia in that segment.

Diagnostic Accuracy

Diagnostic accuracy for obstructive CAD runs roughly comparable to other functional imaging modalities: specificity around 90%, sensitivity around 80%. Sensitivity is meaningfully higher for extensive (multivessel), severe (≥90% diameter reduction) disease involving the LAD with complex morphology, and correspondingly lower for single-vessel, intermediate-severity (50–80%), simple-morphology disease in the circumflex or right coronary distribution.

The ABCDE Protocol

A more comprehensive, multiparametric framework extends stress echo beyond wall motion alone into five combined assessments, using the same transducer for most steps:

• A — Asynergy: regional wall motion abnormality by 2D echo (as above).
• B — B-lines: lung ultrasound, using a simplified four-site scan at the third intercostal space, assessing pulmonary congestion.
• C — LV contractile reserve: the stress/rest ratio of force (systolic pressure ÷ end-systolic volume), or more simply, LV cavity dilatation during stress. Abnormal cutoff is stressor-dependent: ≤1.1 for vasodilators vs. ≤2.0 for exercise or dobutamine, since vasodilators are weaker inotropes.
• D — Coronary flow velocity reserve: PW Doppler of the LAD.
• E — Heart rate reserve: peak/rest heart rate, imaging-independent (ECG-based). Abnormal cutoff again differs by stressor: ≤1.22 for vasodilators vs. ≤1.80 for exercise/dobutamine. Chronotropic incompetence independently predicts worse prognosis regardless of whether ischemia is also induced.

Combining these five parameters into one test gives more comprehensive risk stratification than wall motion scoring alone.

Reasons for Test Termination

Diagnostic endpoints (the test has answered the question): maximum dose or workload reached, target heart rate achieved, obvious echocardiographic positivity (dyssynergy in ≥2 LV segments), severe chest pain, or clear ECG positivity (>2 mV ST-segment shift).

Submaximal, non-diagnostic endpoints (the test must stop before answering the question): intolerable symptoms; hypertension (systolic >220 mmHg or diastolic >120 mmHg); symptomatic hypotension (>40 mmHg drop); supraventricular arrhythmias (SVT, atrial fibrillation); or complex ventricular arrhythmias (sustained VT, frequent polymorphic PVCs).

Safety

Complication rates differ meaningfully by stressor, and this should factor into stressor selection, not just efficacy:

• Exercise: death in roughly 1:10,000 tests; major life-threatening events (MI, VF, sustained VT, stroke) in roughly 1:6,000, per the international stress echo registry.
• Dobutamine: major complications in roughly 1:300 — the highest rate among common stressors, despite being one of the most widely used. In order of frequency: complex ventricular tachyarrhythmias (the most common complication, often independent of ischemia and occurring even at low dose), hypotension, atrial fibrillation, and hypertension (sometimes from dynamic LVOT obstruction in predisposed — e.g., hypertrophic — hearts). A Bezold-Jarisch reflex (vasodepressor response to LV mechanoreceptor stimulation) is a described alternative mechanism for hypotension.
• Dipyridamole: limiting side effects in ~3% of patients (hypotension, SVT, malaise, headache, dyspnea, AFib); major life-threatening complications in roughly 1:1,000 with high-dose testing.
• Adenosine: side effects are frequent and limiting in up to 20% of patients (AV block, hypotension, chest pain, dyspnea, flushing, headache) — but life-threatening complications are rare, roughly 1 fatal MI per 10,000 cases.

Minor-but-limiting side effects prevent reaching maximal pharmacologic stress in under 10% of dobutamine tests and under 5% of dipyridamole tests. Both patient and physician should know the complication rate in advance — it belongs in the informed consent discussion — and pharmacologic stress testing should always be performed with a physician in attendance.

Contraindications worth flagging by stressor: exercise — unstable hemodynamics, uncontrolled hypertension, inability to exercise adequately; dobutamine — complex atrial or ventricular arrhythmia history, moderate-to-severe hypertension; dipyridamole/adenosine — second- or third-degree AV block, sick sinus syndrome, bronchial asthma or bronchospasm tendency (dipyridamole), and patients on chronic dipyridamole shouldn’t receive adenosine testing within 24 hours of withdrawal (unpredictably high adenosine levels). A poor acoustic window limits feasibility in under 5% of referrals with modern harmonic imaging and contrast availability.

Myocardial Viability

Dobutamine echo’s contractile-reserve approach to viability sits alongside genuinely different methodologies: nuclear imaging assesses perfusion (PET) or membrane integrity (SPECT), while cardiac MRI with late gadolinium enhancement detects the increased extracellular space of scar tissue directly. Pooled data across head-to-head studies show a real trade-off rather than one clearly superior technique: nuclear imaging is more sensitive (~90% vs. ~74% for dobutamine echo), but dobutamine echo is more specific (~78% vs. ~57% for nuclear imaging). Regional improvement in segmental function after revascularization has been the most common endpoint used to validate these comparisons.

Clinical Applications Beyond Ischemia Detection

• Prognosis and risk stratification — exercise and pharmacologic stress echo add incremental prognostic information beyond clinical assessment, resting echo, and exercise ECG alone, across CAD, valve disease, and post-MI populations.
• Aortic stenosis — in low-flow, low-gradient AS, true-severe disease has classically been defined by a peak stress mean gradient ≥40 mmHg with AVA ≤1 cm² on dobutamine stress. More recent evaluation, however, found these criteria classify severity poorly against surgical/CT calcium reference standards; projected AVA at a standardized flow rate performs better and is strongly associated with mortality. Notably, absence of flow reserve (stroke volume increase under 20%) — long taught as a marker of poor prognosis — has not held up as an independent prognostic finding in more recent studies and should not be used alone to guide decision-making. See Aortic Stenosis for the broader severity-grading picture.
• Mitral regurgitation — in asymptomatic primary MR, exercise SE can unmask symptoms and assess the sPAP response for risk stratification; in symptomatic patients with at least moderate MR, an MR severity increase of more than one grade, dynamic pulmonary hypertension (sPAP >60 mmHg), absent contractile reserve (EF increase under 5% or GLS increment under 2%), and limited RV contractile recruitment (TAPSE under 18 mm) all flag poor prognosis. In secondary MR, exercise sPAP >60 mmHg carries a markedly elevated event hazard. See Mitral Regurgitation.
• Mitral stenosis — exercise-induced pulmonary hypertension independently predicts mortality even in apparently asymptomatic patients, and is a factor supporting earlier intervention. See Mitral Stenosis.
• Aortic regurgitation — stress echo’s role here is comparatively limited, since the heart-rate increase from either exercise or pharmacologic stress shortens diastole and limits AR severity quantification. Absent contractile reserve (EF change under 5%) in asymptomatic patients does predict later LV systolic dysfunction, but AR severity itself can’t be reliably reclassified with stress.

Appropriateness

A structured appropriateness framework (Class I = appropriate) helps calibrate when stress echo genuinely adds value:

• Class I (appropriate) — uninterpretable ECG or inability to exercise adequately; uncertain coronary stenosis significance; post-revascularization with new or changed symptoms; high-risk preoperative assessment with low exercise tolerance; viability assessment in ischemic cardiomyopathy.
• Class IIb (uncertain) — asymptomatic patients more than 5 years after CABG or more than 2 years after PCI.
• Class III (inappropriate) — asymptomatic, low-risk patients; intermediate-risk preoperative assessment with good exercise tolerance; low pre-test probability with an interpretable ECG and exercise capability; and asymptomatic patients within 5 years of CABG or 2 years of PCI.